Global Market Study on Commercial Aquaculture Vaccines: Industry Proliferating on Back of Rising Prevalence of Bacterial & Viral Infections in Aquaculture Species

Global Market Study on Commercial Aquaculture Vaccines: Industry Proliferating on Back of Rising Prevalence of Bacterial & Viral Infections in Aquaculture Species

  • Persistence Market Research
  • January 2021
  • Healthcare
  • 366 pages

Report Description

Commercial Aquaculture Vaccines Market - Scope of Report

A latest publication by Persistence Market Research on the global commercial aquaculture vaccines market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform over the forecast period of 2020-2030.

Important indicators for successful growth of the commercial aquaculture vaccines market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in this research. This research study can support readers to know the demand for commercial aquaculture vaccines and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the market, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the commercial aquaculture vaccines market. Insights and wisdom presented in this study can be leveraged by shareholders in the commercial aquaculture vaccines market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the commercial aquaculture vaccines market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in this industry can be aided in making suitable company choices to achieve traction in the commercial aquaculture vaccines market.

 Key Questions Answered in Report

  • Which regions will continue to remain the most profitable regional markets for commercial aquaculture vaccines?
  • Which factors will induce a change in demand for commercial aquaculture vaccines during the assessment period?
  • How will changing trends impact the commercial aquaculture vaccines market?
  • What impact does the COVID-19 pandemic have on the market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the commercial aquaculture vaccines market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends in aquaculture vaccination sectors that will impact the market?
  • How can businesses in the commercial aquaculture vaccines market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the commercial aquaculture vaccines market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the commercial aquaculture vaccines market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the commercial aquaculture vaccines market, and makes Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.

Keywords

  • Commercial Aquaculture Vaccines Market
  • Commercial Aquaculture Vaccines Market Share
  • Demand for Commercial Aquaculture Vaccines
  • Sales of Commercial Aquaculture Vaccines
  • Commercial Aquaculture Vaccines Sales Demand
  • Commercial Aquaculture Vaccines Market Forecast
  • Commercial Aquaculture Vaccines Sales Forecast
  • Commercial Aquaculture Vaccines Demand forecast
  • US Commercial Aquaculture Vaccines Market
  • Canada Commercial Aquaculture Vaccines Market
  • Europe Commercial Aquaculture Vaccines Market
  • Middle East Commercial Aquaculture Vaccines market

Countries Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Companies Mentioned

  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Canada inc
  • HIPRA
  • Elanco
  • AQUATRECK ANIMAL HEALTH S.L.
  • MSD Animal Health
  • Zoetis LLC
  • Centrovet Laboratories inc.
  • Intervet-International BV

Have query on this report?

Make an Enquiry

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Market Context 
4.1. Key Regulations 
4.2. Product Adoption analysis

5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.1. Global Healthcare Industry Market Outlook
5.1.2. Global veterinary Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growing Healthcare Expenditure
5.2.2. Adoption of autogenous vaccine Services
5.2.3. Increasing Prevalence of disease
5.2.4. Increasing number of research activities
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis

6. Current COVID19 Statistics and Probable Future Impact
6.1. Current GDP Projection and Probable Impact
6.2. COVID19 and Impact Analysis
6.2.1. Revenue By Fish Species
6.2.2. Revenue By End-User
6.3. 2020 Market Scenario

7. Global Autogenous Vaccine for Aquaculture Market Value (US$ Mn) Analysis 2015-2020 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8. Global Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030, By Fish Species 
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Fish Species, 2015-2020
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Fish Species, 2020-2030
8.3.1. Salmon
8.3.2. Tilapia
8.3.3. Bream
8.3.4. Labris Bergylta
8.3.5. Cyprinus Carpio
8.3.6. Sea Bass
8.3.7. Trout
8.3.8. Cyclopterus Lumpus
8.4. Market Attractiveness Analysis By Fish Species

9. Global Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030, By Pathogen Type 
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Pathogen Type, 2015-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pathogen Type, 2020-2030
9.3.1. Bacteria
9.3.2. Virus
9.4.  Market Attractiveness Analysis By Pathogen Type

10. Global Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030, by End User 
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
10.3.1. Fish Farming companies
10.3.2. Aquatic research institute 
10.4. Market Attractiveness Analysis By End User

11. Global Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2020
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region

12. North America Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2020
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
12.3.1.  By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Fish Species
12.3.3. By Pathogen Type
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis

13. Latin America Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2020
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
13.3.1.  By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Peru
13.3.1.4. Chile
13.3.1.5. Rest of Latin America
13.3.2. By Fish Species
13.3.3. By Pathogen Type
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. Europe Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
14.3.1.  By Country
14.3.1.1. Germany
14.3.1.2. U.K.
14.3.1.3. France
14.3.1.4. Italy
14.3.1.5. Spain
14.3.1.6. Norway
14.3.1.7. Greece
14.3.1.8. Russia
14.3.1.9. Rest of Europe
14.3.2. By Fish Species
14.3.3. By Pathogen Type
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. Asia Pacific Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
15.3.1.  By Country
15.3.1.1. China
15.3.1.2. Singapore
15.3.1.3. Thailand
15.3.1.4. Indonesia
15.3.1.5. Australia & New Zealand
15.3.1.6. Rest of Asia Pacific
15.3.2. By Fish Species
15.3.3. By Pathogen Type
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2020
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
16.3.1.  By Country
16.3.1.1. South Africa
16.3.1.2. Rest of Middle East and Africa
16.3.2. By Fish Species
16.3.3. By Pathogen Type
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis

17. Key and Emerging Countries Autogenous Vaccine for Aquaculture Market Analysis 2015-2020 and Forecast 2020-2030
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Autogenous Vaccine for Aquaculture Market Analysis
17.2.1. By Fish Species
17.2.2. By Pathogen Type
17.2.3. By End User
17.3. Canada Autogenous Vaccine for Aquaculture Market Analysis
17.3.1. By Fish Species
17.3.2. By Pathogen Type
17.3.3. By End User
17.4. Mexico Autogenous Vaccine for Aquaculture Market Analysis
17.4.1. By Fish Species
17.4.2. By Pathogen Type
17.4.3. By End User
17.5. Brazil Autogenous Vaccine for Aquaculture Market Analysis
17.5.1. By Fish Species
17.5.2. By Pathogen Type
17.5.3. By End User
17.6. Chile. Autogenous Vaccine for Aquaculture Market Analysis
17.6.1. By Fish Species
17.6.2. By Pathogen Type
17.6.3. By End User
17.7. U.K. Autogenous Vaccine for Aquaculture Market Analysis
17.7.1. By Fish Species
17.7.2. By Pathogen Type
17.7.3. By End User
17.8. Germany Autogenous Vaccine for Aquaculture Market Analysis
17.8.1. By Fish Species
17.8.2. By Pathogen Type
17.8.3. By End User
17.9. France Autogenous Vaccine for Aquaculture Market Analysis
17.9.1. By Fish Species
17.9.2. By Pathogen Type
17.9.3. By End User
17.10. Italy Autogenous Vaccine for Aquaculture Market Analysis
17.10.1. By Fish Species
17.10.2. By Pathogen Type
17.10.3. By End User
17.11. Spain Autogenous Vaccine for Aquaculture Market Analysis
17.11.1. By Fish Species
17.11.2. By Pathogen Type
17.11.3. By End User
17.12. Norway Autogenous Vaccine for Aquaculture Market Analysis
17.12.1. By Fish Species
17.12.2. By Pathogen Type
17.12.3. By End User
17.13. Greece Autogenous Vaccine for Aquaculture Market Analysis
17.13.1. By Fish Species
17.13.2. By Pathogen Type
17.13.3. By End User
17.14. Russia Autogenous Vaccine for Aquaculture Market Analysis
17.14.1. By Fish Species
17.14.2. By Pathogen Type
17.14.3. By End User
17.15. China Autogenous Vaccine for Aquaculture Market Analysis
17.15.1. By Fish Species
17.15.2. By Pathogen Type
17.15.3. By End User
17.16. Singapore Autogenous Vaccine for Aquaculture Market Analysis
17.16.1. By Fish Species
17.16.2. By Pathogen Type
17.16.3. By End User
17.17. Thailand Autogenous Vaccine for Aquaculture Market Analysis
17.17.1. By Fish Species
17.17.2. By Pathogen Type
17.17.3. By End User
17.18. Indonesia Autogenous Vaccine for Aquaculture Market Analysis
17.18.1. By Fish Species
17.18.2. By Pathogen Type
17.18.3. By End User
17.19. Australia Autogenous Vaccine for Aquaculture Market Analysis
17.19.1. By Fish Species
17.19.2. By Pathogen Type
17.19.3. By End User
17.20. South Africa Autogenous Vaccine for Aquaculture Market Analysis
17.20.1. By Fish Species
17.20.2. By Pathogen Type
17.20.3. By End User

18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies 
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
18.3.1. By Regional footprint of Players

19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive 
19.3.1. IDT Biologika GmbH (Ridgeway Biologicals Ltd)
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.1.5.1. Marketing Strategy
19.3.1.5.2. Product Strategy
19.3.1.5.3. Channel Strategy
19.3.2. MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.2.5.1. Marketing Strategy
19.3.2.5.2. Product Strategy
19.3.2.5.3. Channel Strategy
19.3.3. Ceva Biovac
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.3.5.1. Marketing Strategy
19.3.3.5.2. Product Strategy
19.3.3.5.3. Channel Strategy
19.3.4. Zoetis (PHARMAQAS)
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.4.5.1. Marketing Strategy
19.3.4.5.2. Product Strategy
19.3.4.5.3. Channel Strategy
19.3.5. Vaxxinova
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.5.5.1. Marketing Strategy
19.3.5.5.2. Product Strategy
19.3.5.5.3. Channel Strategy
19.3.6. Barramundi Asia Pte Ltd.(UVAXX Asia)
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
19.3.6.4. Sales Footprint
19.3.6.5. Strategy Overview
19.3.6.5.1. Marketing Strategy
19.3.6.5.2. Product Strategy
19.3.6.5.3. Channel Strategy
19.3.7. HIPRA 
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
19.3.7.4. Sales Footprint
19.3.7.5. Strategy Overview
19.3.7.5.1. Marketing Strategy
19.3.7.5.2. Product Strategy
19.3.7.5.3. Channel Strategy
19.3.8. AniCon Labor GmbH
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
19.3.8.4. Sales Footprint
19.3.8.5. Strategy Overview
19.3.8.5.1. Marketing Strategy
19.3.8.5.2. Product Strategy
19.3.8.5.3. Channel Strategy
19.3.9. sanphar (ipeve)
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
19.3.9.4. Sales Footprint
19.3.9.5. Strategy Overview
19.3.9.5.1. Marketing Strategy
19.3.9.5.2. Product Strategy
19.3.9.5.3. Channel Strategy
19.3.10. Kennebec River Biosciences
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
19.3.10.4. Sales Footprint
19.3.10.5. Strategy Overview
19.3.10.5.1. Marketing Strategy
19.3.10.5.2. Product Strategy
19.3.10.5.3. Channel Strategy

20.  Assumptions and Acronyms Used

21. Research Methodology

List of Table

Table 1: Global Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Fish Species
Table 2: Global Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Pathogen Type
Table 3: Global Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 4: Global Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 5: North America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Fish Species
Table 6: North America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Pathogen Type
Table 7: North America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 8: North America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 9: Latin America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Fish Species
Table 10: Latin America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Pathogen Type
Table 11: Latin America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 12: Latin America Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 13: Europe Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Fish Species
Table 14: Europe Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Pathogen Type
Table 15: Europe Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 16: Europe Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 17: Asia Pacific Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Fish Species
Table 18: Asia Pacific Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Pathogen Type
Table 19: Asia Pacific Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 20: Asia Pacific Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 21: Middle East and Africa Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Fish Species
Table 22: Middle East and Africa Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Pathogen Type
Table 23: Middle East and Africa Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 24: Middle East and Africa Autogenous Vaccine for Aquaculture Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Success Stories

Our Clients